GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » CHO Pharma Inc (ROCO:6586) » Definitions » Net Interest Income (for Banks)

CHO Pharma (ROCO:6586) Net Interest Income (for Banks)


View and export this data going back to 2017. Start your Free Trial

What is CHO Pharma Net Interest Income (for Banks)?

Net Interest Income only applies to banks.


CHO Pharma Business Description

Industry
Traded in Other Exchanges
N/A
Address
No. 3, Park Street, 18F, Building F, Nangang, Taipei, TWN, 11503
CHO Pharma Inc is a biopharmaceutical company mainly focused on the development and commercialization of innovative products based on the proprietary glycan engineering technologies. It offers antibodies, such as CHO-H01, CHO-H02, CHO-A04 for cancer; CHO-H03, an antibody for autoimmune disease; CHO-S05 dual-effect anti-flu drugs; and CHO-V06 glycan-based vaccines and drugs.